Počet záznamov: 1
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
Názov Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications Autor Jakubíková Jana 1976- SAVEXONK - Ústav experimentálnej onkológie SAV ORCID Cholujová Dana 1975- SAVEXONK - Ústav experimentálnej onkológie SAV Sedlák Ján 1957- SAVEXONK - Ústav experimentálnej onkológie SAV Spoluautori Adamia Sophia Kost-Alimova Maria Klippel Steffen Cervi David Daley John F. Kong Sun-Young Leiba Merav Blotta Simona Ooi Melissa Delmore Jake Laubach Jacob Richardson Paul G. Anderson Kenneth C. Mitsiades Constantine S. Zdroj.dok. Blood. Vol. 117, no. 17 (2011), p. 4409-4419 Jazyk dok. eng - angličtina Krajina US - Spojené štáty Poznámky Slovak R&D Agency grant VVCE-0001-07 (J.S.) Druh dok. rozpis článkov z periodík (rbx) Ohlasy QUINN, John - YONG, Kwee L. Cell cycle regulation and myeloma precursor cells. In Myeloma: Pathology, Diagnosis, and Treatment, 2011-01-01, pp. 39-47. HOFMEISTER, Craig C. - YANG, Xiaoxia - PICHIORRI, Flavia - CHEN, Ping - ROZEWSKI, Darlene M. - JOHNSON, Amy J. - LEE, Seungsoo - LIU, Zhongfa - GARR, Celia L. - HADE, Erinn M. - JI, Jia - SCHAAF, Larry J. - BENSON, Don M. - KRAUT, Eric H. - HICKS, William J. - CHAN, Kenneth K. - CHEN, Ching Shih - FARAG, Sherif S. - GREVER, Michael R. - BYRD, John C. - PHELPS, Mitch A. Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: Evidence for lenalidomide-CCI-779 interaction via P-glycoprotein. In Journal of Clinical Oncology. ISSN 0732183X, 2011-09-01, 29, 25, pp. 3427-3434. JIANG, Hua - YI, Qing - HOU, Jian. Strategic consideration on treatment of multiple myeloma. In Chinese Medical Journal. ISSN 03666999, 2011-10-01, 124, 19, pp. 2965-2968. PEI, Xin Yan - DAI, Yun - YOUSSEFIAN, Leena E. - CHEN, Shuang - BODIE, Wesley W. - TAKABATAKE, Yukie - FELTHOUSEN, Jessica - ALMENARA, Jorge A. - KRAMER, Lora B. - DENT, Paul - GRANT, Steven. Cytokinetically quiescent (G0/G1) human multiple myeloma cells are susceptible to simultaneous inhibition of Chk1 and MEK1/2. In Blood. ISSN 00064971, 2011-11-10, 118, 19, pp. 5189-5200. CHANG, Xiu Bao - KEITH STEWART, A. What is the functional role of the thalidomide binding protein cereblon? In International Journal of Biochemistry and Molecular Biology, 2011-12-01, 2, 3, pp. 287-294. KUMAR, V. - CHHIBBER, S. Thalidomide: An old drug with new action. In Journal of Chemotherapy. ISSN 1120009X, 2011-12-01, 23, 6, pp. 326-334. ZHENG, D.W. - LIAO, S. - ZHU, G.C. - LUO, G.Q. - XIAO, S.S. - HE, J.Y. - PEI, Z. - LI, G.Y. - ZHOU, Y.H. CD38 is a putative functional marker for side population cells in human nasopharyngeal carcinoma cell lines. In MOLECULAR CARCINOGENESIS. ISSN 0899-1987, MAR 2016, vol. 55, no. 3, p. 300-311. FRANQUI-MACHIN, R. - WENDLANDT, E.B. - JANZ, S. - ZHAN, F.H. - TRICOT, G. Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?. In ONCOTARGET. ISSN 1949-2553, DEC 1 2015, vol. 6, no. 38, p. 40496-40506. RAJA, A.M. - XU, S.Y. - ZHUO, S.M. - TAI, D.C.S. - SUN, W.X. - SO, P.T.C. - WELSCH, R.E. - CHEN, C.S. - YU, H. Differential remodeling of extracellular matrices by breast cancer initiating cells. In JOURNAL OF BIOPHOTONICS. ISSN 1864-063X, OCT 2015, vol. 8, no. 10, p. 804-815. DU, J. - LIU, S.Y. - HE, J. - LIU, X. - QU, Y. - YAN, W.Q. - FAN, J.L. - LI, R. - XI, H. - FU, W.J. - ZHANG, C.Y. - YANG, J. - HOU, J. MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma. In ONCOTARGET. ISSN 1949-2553, JUN 20 2015, vol. 6, no. 17, p. 14993-15007. RANINGA, P.V. - DI TRAPANI, G. - VUCKOVIC, S. - BHATIA, M. - TONISSEN, K.F. Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma. In ONCOTARGET. ISSN 1949-2553, JUN 20 2015, vol. 6, no. 17, p. 15410-15424. WEN, J.G. - TAO, W.J. - KUIATSE, I. - LIN, P. - FENG, Y.D. - JONES, R.J. - ORLOWSKI, R.Z. - ZU, Y.L. Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions. In INTERNATIONAL JOURNAL OF CANCER. ISSN 0020-7136, MAR 1 2015, vol. 136, no. 5, p. 991-1002. YANG, Y. - SHI, J.M. - GU, Z.M. - SALAMA, M.E. - DAS, S. - WENDLANDT, E. - XU, H. - HUANG, J.W. - TAO, Y. - HAO, M. - FRANQUI, R. - LEVASSEUR, D. - JANZ, S. - TRICOT, G. - ZHAN, F.H. Bruton Tyrosine Kinase Is a Therapeutic Target in Stem-like Cells from Multiple Myeloma. In CANCER RESEARCH. ISSN 0008-5472, FEB 1 2015, vol. 75, no. 3, p. 594-604. YANG, D.Y. - REN, J.H. - GUO, X.N. - GUO, X.L. - CAI, X.Y. - GUO, X.F. - ZHANG, J.N. Lenalidomide affect expression level of cereblon protein in multiple myeloma cell line RPMI8226. In GENETICS AND MOLECULAR RESEARCH. ISSN 1676-5680, 2015, vol. 14, no. 4, p. 13588-13594. CAHU, J. - SOLA, B. Emergence of cancer stem cells or tumor-initiating/propagating cells and relapse in multiple myeloma. In BULLETIN DU CANCER. ISSN 0007-4551, DEC 2014, vol. 101, no. 12, p. 1074-1079. ALLEGRA, A. - ALONCI, A. - PENNA, G. - INNAO, V. - GERACE, D. - ROTONDO, F. - MUSOLINO, C. The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets. In CANCER INVESTIGATION. ISSN 0735-7907, OCT 2014, vol. 32, no. 9, p. 470-495. WEN, J.G. - LI, H.W. - TAO, W.J. - SAVOLDO, B. - FOGLESONG, J.A. - KING, L.C. - ZU, Y.L. - CHANG, C.C. High throughput quantitative reverse transcription PCR assays revealing over-expression of cancer testis antigen genes in multiple myeloma stem cell-like side population cells. In BRITISH JOURNAL OF HAEMATOLOGY. ISSN 0007-1048, SEP 2014, vol. 166, no. 5, p. 711-719. PARK, J. - BAE, E.K. - LEE, C. - CHOI, J.H. - JUNG, W.J. - AHN, K.S. - YOON, S.S. Establishment and characterization of bortezomib-resistant U266 cell line: Constitutive activation of NF-kappa B-mediated cell signals and/or alterations of ubiquitylation-related genes reduce bortezomib-induced apoptosis. In BMB REPORTS. ISSN 1976-6696, MAY 31 2014, vol. 47, no. 5, p. 274-279. ABE, M. - HARADA, T. - MATSUMOTO, T. Concise Review: Defining and Targeting Myeloma Stem Cell-Like Cells. In STEM CELLS. ISSN 1066-5099, MAY 2014, vol. 32, no. 5, p. 1067-1073. PAINO, T. - SARASQUETE, M.E. - PAIVA, B. - KRZEMINSKI, P. - SAN-SEGUNDO, L. - CORCHETE, L.A. - REDONDO, A. - GARAYOA, M. - GARCIA-SANZ, R. - GUTIERREZ, N.C. - OCIO, E.M. - SAN-MIGUEL, J.F. Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138(++) and CD138(low) Subpopulations in Multiple Myeloma Cell Lines. In PLOS ONE. ISSN 1932-6203, MAR 21 2014, vol. 9, no. 3. FAN, J.L. - ZHANG, J. - DONG, L.W. - FU, W.J. - DU, J. - SHI, H.G. - JIANG, H. - YE, F. - XI, H. - ZHANG, C.Y. - HOU, J. - WANG, H.Y. URI regulates tumorigenicity and chemotherapeutic resistance of multiple myeloma by modulating IL-6 transcription. In CELL DEATH & DISEASE. ISSN 2041-4889, MAR 2014, vol. 5. JINESH, G.G. - WILLIS, D.L. - KAMAT, A.M. Bladder Cancer Stem Cells: Biological and Therapeutic Perspectives. In CURRENT STEM CELL RESEARCH & THERAPY. ISSN 1574-888X, MAR 2014, vol. 9, no. 2, p. 89-101. TANNO, T. - LIM, Y.T. - WANG, Q.J. - CHESI, M. - BERGSAGEL, P.L. - MATTHEWS, G. - JOHNSTONE, R.W. - GHOSH, N. - BORRELLO, I. - HUFF, C.A. - MATSUI, W. Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells. In BLOOD. ISSN 0006-4971, JAN 30 2014, vol. 123, no. 5, p. 725-733. SU, J. - ZHANG, L. - ZHANG, W. - CHOI, D.S. - WEN, J.G. - JIANG, B.N. - CHANG, C.C. - ZHOU, X.B. Targeting the Biophysical Properties of the Myeloma Initiating Cell Niches: A Pharmaceutical Synergism Analysis Using Multi-Scale Agent-Based Modeling. In PLOS ONE. ISSN 1932-6203, JAN 27 2014, vol. 9, no. 1. LI, L. - MARGOLIN, D.A. Cancer Stem Cells and the Stromal Microenvironment. In CANCER STEM CELLS. 2014, p. 273-286. THIAGO, L.S. - PEREZ-ANDRES, M. - BALANZATEGUI, A. - SARASQUETE, M.E. - PAIVA, B. - JARA-ACEVEDO, M. - BARCENA, P. - SANCHEZ, M.L. - ALMEIDA, J. - GONZALEZ, M. - SAN MIGUEL, J.F. - GARCIA-SANZ, R. - ORFAO, A. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance. In HAEMATOLOGICA. ISSN 0390-6078, JAN 2014, vol. 99, no. 1, p. 155-162. MORGENROTH, A. - VOGG, A.T.J. - ZLATOPOLSKIY, B.D. - SILUSCHEK, M. - OEDEKOVEN, C. - MOTTAGHY, F.M. Breaking the Invulnerability of Cancer Stem Cells: Two-Step Strategy to Kill the Stem-like Cell Subpopulation of Multiple Myeloma. In MOLECULAR CANCER THERAPEUTICS. ISSN 1535-7163, JAN 2014, vol. 13, no. 1, p. 144-153. QUINN, J. - YONG, K.L. Cell cycle regulation and myeloma precursor cells. In MYELOMA: PATHOLOGY, DIAGNOSIS, AND TREATMENT. 2014, p. 39-47. HARADA, T. - OZAKI, S. - ODA, A. - TSUJI, D. - IKEGAME, A. - IWASA, M. - UDAKA, K. - FUJII, S. - NAKAMURA, S. - MIKI, H. - KAGAWA, K. - KURODA, Y. - KAWAI, S. - ITOH, K. - YAMADA-OKABE, H. - MATSUMOTO, T. - ABE, M. Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors. In PLOS ONE. ISSN 1932-6203, DEC 26 2013, vol. 8, no. 12. KAWANO, Y. - KIKUKAWA, Y. - FUJIWARA, S. - WADA, N. - OKUNO, Y. - MITSUYA, H. - HATA, H. Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells. In INTERNATIONAL JOURNAL OF ONCOLOGY. ISSN 1019-6439, DEC 2013, vol. 43, no. 6, p. 1809-1816. GREENBERG, A.J. - WALTERS, D.K. - KUMAR, S.K. - RAJKUMAR, S.V. - JELINEK, D.F. Responsiveness of cytogenetically discrete human myeloma cell lines to lenalidomide: lack of correlation with cereblon and interferon regulatory factor 4 expression levels. In EUROPEAN JOURNAL OF HAEMATOLOGY. ISSN 0902-4441, DEC 2013, vol. 91, no. 6, p. 504-513. HAJEK, R. - OKUBOTE, S.A. - SVACHOVA, H. Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma. In BRITISH JOURNAL OF HAEMATOLOGY. ISSN 0007-1048, DEC 2013, vol. 163, no. 5, p. 551-564. DOU, J. - HE, X.F. - LIU, Y.J. - HUANG, Z.H. - YANG, C.P. - SHI, F.F. - CHEN, D.Y. - GU, N. Targeted therapeutic effect of anti-ABCG2 antibody combined with nano silver and vincristine on mouse myeloma cancer stem cells. In JOURNAL OF NANOPARTICLE RESEARCH. ISSN 1388-0764, NOV 22 2013, vol. 15, no. 12. PAIVA, B. - PAINO, T. - SAYAGUES, J.M. - GARAYOA, M. - SAN-SEGUNDO, L. - MARTIN, M. - MOTA, I. - SANCHEZ, M.L. - BARCENA, P. - AIRES-MEJIA, I. - CORCHETE, L. - JIMENEZ, C. - GARCIA-SANZ, R. - GUTIERREZ, N.C. - OCIO, E.M. - MATEOS, M.V. - VIDRIALES, M.B. - ORFAO, A. - SAN MIGUEL, J.F. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile. In BLOOD. ISSN 0006-4971, NOV 21 2013, vol. 122, no. 22, p. 3591-3598. DIMOPOULOS, M.A. - TERPOS, E. - NIESVIZKY, R. How lenalidomide is changing the treatment of patients with multiple myeloma. In CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. ISSN 1040-8428, OCT 1 2013, vol. 88, p. S23-S35. ORLOWSKI, R.Z. Why Proteasome Inhibitors Cannot ERADicate Multiple Myeloma. In CANCER CELL. ISSN 1535-6108, SEP 9 2013, vol. 24, no. 3, p. 275-277. SHORTT, J. - HSU, A.K. - JOHNSTONE, R.W. Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy. In ONCOGENE. ISSN 0950-9232, SEP 5 2013, vol. 32, no. 36, p. 4191-4202. YANG, Y. - SHI, J.M. - TOLOMELLI, G. - XU, H.W. - XIA, J.L. - WANG, H. - ZHOU, W. - ZHOU, Y. - DAS, S. - GU, Z.M. - LEVASSEUR, D. - ZHAN, F.H. - TRICOT, G. RAR alpha 2 expression confers myeloma stem cell features. In BLOOD. ISSN 0006-4971, AUG 22 2013, vol. 122, no. 8, p. 1437-1447. PODBEREZIN, M. - WEN, J.G. - CHANG, C.C. Cancer Stem Cells A Review of Potential Clinical Applications. In ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. ISSN 0003-9985, AUG 2013, vol. 137, no. 8, p. 1111-1116. YANG, C.P. - HE, X.F. - CHEN, J.S. - CHEN, D.Y. - LIU, Y.J. - XIONG, F. - SHI, F.F. - DOU, J. - GU, N. Fe3O4 nanoparticle loaded paclitaxel induce multiple myeloma apoptosis by cell cycle arrest and increase cleavage of caspases in vitro. In JOURNAL OF NANOPARTICLE RESEARCH. ISSN 1388-0764, AUG 2013, vol. 15, no. 8. STOREY, K.B. - WU, C.W. Stress response and adaptation: A new molecular toolkit for the 21st century. In COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY. ISSN 1095-6433, AUG 2013, vol. 165, no. 4, p. 417-428. POTLURI, V. - NOOTHI, S.K. - VALLABHAPURAPU, S.D. - YOON, S.O. - DRISCOLL, J.J. - LAWRIE, C.H. - VALLABHAPURAPU, S. Transcriptional Repression of Bim by a Novel YY1-RelA Complex Is Essential for the Survival and Growth of Multiple Myeloma. In PLOS ONE. ISSN 1932-6203, JUL 10 2013, vol. 8, no. 7. SCHULER, J. - EWERTH, D. - WALDSCHMIDT, J. - WASCH, R. - ENGELHARDT, M. Preclinical models of multiple myeloma: a critical appraisal. In EXPERT OPINION ON BIOLOGICAL THERAPY. ISSN 1471-2598, JUN 2013, vol. 13, p. S111-S123. MAIGA, S. - GOMEZ-BOUGIE, P. - BONNAUD, S. - GRATAS, C. - MOREAU, P. - LE GOUILL, S. - PELLAT-DECEUNYNCK, C. - AMIOT, M. Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myeloma. In BRITISH JOURNAL OF CANCER. ISSN 0007-0920, MAY 14 2013, vol. 108, no. 9, p. 1801-1806. HAWLEY, T.S. - RIZ, I. - YANG, W.J. - WAKABAYASHI, Y. - DEPALMA, L. - CHANG, Y.T. - PENG, W.Q. - ZHU, J. - HAWLEY, R.G. Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1. In AMERICAN JOURNAL OF HEMATOLOGY. ISSN 0361-8609, APR 2013, vol. 88, no. 4, p. 265-272. NARA, M. - TESHIMA, K. - WATANABE, A. - ITO, M. - IWAMOTO, K. - KITABAYASHI, A. - KUME, M. - HATANO, Y. - TAKAHASHI, N. - IIDA, S. - SAWADA, K. - TAGAWA, H. Bortezomib Reduces the Tumorigenicity of Multiple Myeloma via Downregulation of Upregulated Targets in Clonogenic Side Population Cells. In PLOS ONE. ISSN 1932-6203, MAR 4 2013, vol. 8, no. 3. HOSEN, N. Multiple myeloma-initiating cells. In INTERNATIONAL JOURNAL OF HEMATOLOGY. ISSN 0925-5710, MAR 2013, vol. 97, no. 3, p. 306-312. CHAIDOS, A. - BARNES, C.P. - COWAN, G. - MAY, P.C. - MELO, V. - HATJIHARISSI, E. - PAPAIOANNOU, M. - HARRINGTON, H. - DOOLITTLE, H. - TERPOS, E. - DIMOPOULOS, M. - ABDALLA, S. - YARRANTON, H. - NARESH, K. - FORONI, L. - REID, A. - RAHEMTULLA, A. - STUMPF, M. - ROBERTS, I. - KARADIMITRIS, A. Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma. In BLOOD. ISSN 0006-4971, JAN 10 2013, vol. 121, no. 2, p. 318-328. LIN, M.G. - LIU, L.P. - LI, C.Y. - ZHANG, M. - CHEN, Y.L. - QIN, J. - GU, Y.Y. - LI, Z. - WU, X.L. - MO, S.L. Scutellaria Extract Decreases the Proportion of Side Population Cells in a Myeloma Cell Line by Down-regulating the Expression of ABCG2 Protein. In ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. ISSN 1513-7368, 2013, vol. 14, no. 12, p. 7179-7186. YANG, C.P. - WANG, J. - CHEN, D.Y. - CHEN, J.S. - XIONG, F. - ZHANG, H.Y. - ZHANG, Y.X. - GU, N. - DOU, J. Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-)CD34(-) tumor stem-like cells in multiple myeloma-bearing mice. In INTERNATIONAL JOURNAL OF NANOMEDICINE. ISSN 1178-2013, 2013, vol. 8, p. 1439-1449. CAHU, J. - BUSTANY, S. - SOLA, B. Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells. In CELL DEATH & DISEASE. ISSN 2041-4889, DEC 2012, vol. 3. BOUCHER, K. - PARQUET, N. - WIDEN, R. - SHAIN, K. - BAZ, R. - ALSINA, M. - KOOMEN, J. - ANASETTI, C. - DALTON, W. - PEREZ, L.E. Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow. In CLINICAL CANCER RESEARCH. ISSN 1078-0432, NOV 15 2012, vol. 18, no. 22, p. 6155-6168. BORRELLO, I. Can we change the disease biology of multiple myeloma?. In LEUKEMIA RESEARCH. ISSN 0145-2126, NOV 2012, vol. 36, p. S3-S12. THULIEN, K.J. - BELCH, A.R. - REIMAN, T. - PILARSKI, L.M. In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival. In MOLECULAR CANCER. ISSN 1476-4598, OCT 19 2012, vol. 11. IKEGAME, A. - OZAKI, S. - TSUJI, D. - HARADA, T. - FUJII, S. - NAKAMURA, S. - MIKI, H. - NAKANO, A. - KAGAWA, K. - TAKEUCHI, K. - ABE, M. - WATANABE, K. - HIASA, M. - KIMURA, N. - KIKUCHI, Y. - SAKAMOTO, A. - HABU, K. - ENDO, M. - ITOH, K. - YAMADA-OKABE, H. - MATSUMOTO, T. Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors. In LEUKEMIA. ISSN 0887-6924, SEP 2012, vol. 26, no. 9, p. 2124-2134. HOSEN, N. - MATSUOKA, Y. - KISHIDA, S. - NAKATA, J. - MIZUTANI, Y. - HASEGAWA, K. - MUGITANI, A. - ICHIHARA, H. - AOYAMA, Y. - NISHIDA, S. - TSUBOI, A. - FUJIKI, F. - TATSUMI, N. - NAKAJIMA, H. - HINO, M. - KIMURA, T. - YATA, K. - ABE, M. - OKA, Y. - OJI, Y. - KUMANOGOH, A. - SUGIYAMA, H. CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients. In LEUKEMIA. ISSN 0887-6924, SEP 2012, vol. 26, no. 9, p. 2135-2141. KASSAMBARA, A. - HOSE, D. - MOREAUX, J. - REME, T. - TORRENT, J. - ROSSI, J.F. - GOLDSCHMIDT, H. - KLEIN, B. Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma. In PLOS ONE. ISSN 1932-6203, JUL 31 2012, vol. 7, no. 7. LU, P. - SUN, H.F. - ZHANG, L.X. - HOU, H.L. - ZHANG, L. - ZHAO, F.Y. - GE, C. - YAO, M. - WANG, T.P. - LI, J.J. Isocorydine Targets the Drug-Resistant Cellular Side Population through PDCD4-Related Apoptosis in Hepatocellular Carcinoma. In MOLECULAR MEDICINE. ISSN 1076-1551, JUL 2012, vol. 18, no. 7, p. 1136-1146. SWIFT, B.E. - WILLIAMS, B.A. - KOSAKA, Y. - WANG, X.H. - MEDIN, J.A. - VISWANATHAN, S. - MARTINEZ-LOPEZ, J. - KEATING, A. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model. In HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. ISSN 0390-6078, JUL 2012, vol. 97, no. 7, p. 1020-1028. PAINO, T. - OCIO, E.M. - PAIVA, B. - SAN-SEGUNDO, L. - GARAYOA, M. - GUTIERREZ, N.C. - SARASQUETE, M.E. - PANDIELLA, A. - ORFAO, A. - SAN MIGUEL, J.F. CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype. In HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. ISSN 0390-6078, JUL 2012, vol. 97, no. 7, p. 1110-1114. DRAIN, S. - CATHERWOOD, M.A. - BJOURSON, A.J. - DRAKE, M.B. - KETTLE, P.J. - ALEXANDER, H.D. Neither P-gp SNP variants, P-gp expression nor functional P-gp activity predicts MDR in a preliminary study of plasma cell myeloma. In CYTOMETRY PART B-CLINICAL CYTOMETRY. ISSN 1552-4949, JUL 2012, vol. 82B, no. 4, p. 229-237. LEE, C.G. - DAS, B. - LIN, T.L. - GRIMES, C. - ZHANG, X. - LAVEZZI, T. - HUANG, L. - COLE, J. - YAU, L. - LI, L. A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential. In BRITISH JOURNAL OF HAEMATOLOGY. ISSN 0007-1048, JUL 2012, vol. 158, no. 1, p. 79-90. MARUN, C.S.D. - BELCH, A.R. - PILARSKI, L.M. In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival. In AMERICAN JOURNAL OF HEMATOLOGY. ISSN 0361-8609, JUN 2012, vol. 87, no. 6, p. 579-587. ROUSSEAU, C. - FERRER, L. - SUPIOT, S. - BARDIES, M. - DAVODEAU, F. - FAIVRE-CHAUVET, A. - BAUMGARTNER, P. - WIJDENES, J. - LACOMBE, M. - BARBET, J. - GUILLAUME, T. - MOREAU, P. - HAROUSSEAU, J.L. - KRAEBER-BODERE, F. - CHEREL, M. Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients. In TUMOR BIOLOGY. ISSN 1010-4283, JUN 2012, vol. 33, no. 3, SI, p. 679-688. MCCUBREY, J.A. - STEELMAN, L.S. - ABRAMS, S.L. - MISAGHIAN, N. - CHAPPELL, W.H. - BASECKE, J. - NICOLETTI, F. - LIBRA, M. - LIGRESTI, G. - STIVALA, F. - MAKSI-MOVIC-IVANIC, D. - MIJATOVIC, S. - MONTALTO, G. - CERVELLO, M. - LAIDLER, P. - BONATI, A. - EVANGELISTI, C. - COCCO, L. - MARTELLI, A.M. Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy. In CURRENT PHARMACEUTICAL DESIGN. ISSN 1381-6128, MAY 2012, vol. 18, no. 13, p. 1784-1795. CHIRON, D. - MAIGA, S. - DESCAMPS, G. - MOREAU, P. - LE GOUILL, S. - MARIONNEAU, S. - OUILLER, T. - MOREAUX, J. - KLEIN, B. - BATAILLE, R. - AMIOT, M. - PELLAT-DECEUNYNCK, C. Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells. In BLOOD CELLS MOLECULES AND DISEASES. ISSN 1079-9796, APR 15 2012, vol. 48, no. 4, p. 247-253. NATARAJAN, K. - XIE, Y. - BAER, M.R. - ROSS, D.D. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. In BIOCHEMICAL PHARMACOLOGY. ISSN 0006-2952, APR 15 2012, vol. 83, no. 8, SI, p. 1084-1103. SCHECTER, J. - GALILI, N. - RAZA, A. MDS: Refining existing therapy through improved biologic insights. In BLOOD REVIEWS. ISSN 0268-960X, MAR 2012, vol. 26, no. 2, p. 73-80. CHIRON, D. - SURGET, S. - MAIGA, S. - BATAILLE, R. - MOREAU, P. - LE GOUILL, S. - AMIOT, M. - PELLAT-DECEUNYNCK, C. The peripheral CD138+population but not the CD138-population contains myeloma clonogenic cells in plasma cell leukaemia patients. In BRITISH JOURNAL OF HAEMATOLOGY. ISSN 0007-1048, MAR 2012, vol. 156, no. 5, p. 679-683. VALLET, S. - WITZENS-HARIG, M. - JAEGER, D. - PODAR, K. Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignancies. In EXPERT OPINION ON PHARMACOTHERAPY. ISSN 1465-6566, MAR 2012, vol. 13, no. 4, p. 473-494. GENG, C.Y. - LIU, N.A. - YANG, G.Z. - LIU, A.J. - LENG, Y. - WANG, H.J. - LI, L.H. - WU, Y. - LI, Y.C. - CHEN, W.M. Differential Protein Expression Profile Between CD20 Positive and Negative Cells of the NCI-H929 Cell Line. In ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. ISSN 1513-7368, 2012, vol. 13, no. 11, p. 5409-5413. GRIMALDI, C. - CHIARINI, F. - TABELLINI, G. - RICCI, F. - TAZZARI, P.L. - BATTISTELLI, M. - FALCIERI, E. - BORTUL, R. - MELCHIONDA, F. - IACOBUCCI, I. - PAGLIARO, P. - MARTINELLI, G. - PESSION, A. - BARATA, J.T. - MCCUBREY, J.A. - MARTELLI, A.M. AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. In LEUKEMIA. ISSN 0887-6924, JAN 2012, vol. 26, no. 1, p. 91-100. ZHENG, Danwei - LIAO, Shan - ZHU, Guangchao - ZHOU, Yanhong - LI, Guiyuan. Side population cells and progress in cancer stem cell research. In Journal of Central South University (Medical Sciences). ISSN 16727347, 2014-01-01, 39, 5, pp. 525-531. GOODWIN JINESH, G. - WILLIS, Daniel Levi - KAMAT, Ashish M. Bladder cancer stem cells: Biological and therapeutic perspectives. In Current Stem Cell Research and Therapy. ISSN 1574888X, 2014-01-30, 9, 2, pp. 89-101. SUN, Zhi Peng - WANG, Xue Jian - FANG, Chun Yan - DAI, Gong - XU, Wen Fang. Aminopeptidase N: A therapeutic target in human liver cancer stem cells. In Journal of International Pharmaceutical Research. ISSN 16740440, 2014-01-01, 41, 5, pp. 522-527. LI, Li - COLE, John - MARGOLIN, David A. Cancer stem cell and stromal microenvironment. In Ochsner Journal. ISSN 15245012, 2013-03-25, 13, 1, pp. 109-118. MAGRANGEAS, F. - AVET-LOISEAU, H. - GOURAUD, W. - LODÉ, L. - DECAUX, O. - GODMER, P. - GARDERET, L. - VOILLAT, L. - FACON, T. - STOPPA, A. M. - MARIT, G. - HULIN, C. - CASASSUS, P. - TIAB, M. - VOOG, E. - RANDRIAMALALA, E. - ANDERSON, K. C. - MOREAU, P. - MUNSHI, N. C. - MINVIELLE, S. Minor clone provides a reservoir for relapse in multiple myeloma. In Leukemia. ISSN 08876924, 2013-02-01, 27, 2, pp. 473-481. YAN, W.Q. - DU, J. - DU, Y.Z. - PU, H.L. - LIU, S.Y. - HE, J. - ZHANG, J. - HOU, J. Fenretinide targets the side population in myeloma cell line NCI-H929 and potentiates the efficacy of antimyeloma with bortezomib and dexamethasone regimen. In LEUKEMIA RESEARCH. ISSN 0145-2126, DEC 2016, vol. 51, p. 32-40. SCHIBLER, J. - TOMANEK-CHALKLEY, A.M. - REEDY, J.L. - ZHAN, F.H. - SPITZ, D.R. - SCHULTZ, M.K. - GOEL, A. Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells. In PLOS ONE. ISSN 1932-6203, NOV 30 2016, vol. 11, no. 11. ABDI, J. - JIAN, H. - CHANG, H. Role of micro-RNAs in drug resistance of multiple myeloma. In ONCOTARGET. ISSN 1949-2553, SEP 13 2016, vol. 7, no. 37, p. 60723-60735. WEI, Z.T. - LV, S. - WANG, Y.S. - SUN, M.Y. - CHI, G.F. - GUO, J. - SONG, P.Y. - FU, X.Y. - ZHANG, S.L. - LI, Y.L. Biological characteristics of side population cells in a self-established human ovarian cancer cell line. In ONCOLOGY LETTERS. ISSN 1792-1074, JUL 2016, vol. 12, no. 1, p. 41-48. KRISHNAN, S.R. - JAISWAL, R. - BROWN, R.D. - LUK, F. - BEBAWY, M. Multiple myeloma and persistence of drug resistance in the age of novel drugs. In INTERNATIONAL JOURNAL OF ONCOLOGY. ISSN 1019-6439, JUL 2016, vol. 49, no. 1, p. 33-50. GAO, M.J. - KONG, Y.Y. - YANG, G. - GAO, L. - SHI, J.M. Multiple myeloma cancer stem cells. In ONCOTARGET. ISSN 1949-2553, JUN 7 2016, vol. 7, no. 23, p. 35466-35477. LUM, L.G. - THAKUR, A. - KONDADASULA, V. - AL-KADHIMI, Z. - DEOL, A. - TOMASZEWSKI, E.N. - YANO, H. - SCHALK, D.L. - AYASH, L. - ZONDER, J.A. - UBERTI, J.P. - ABIDI, M.H. - RATANATHARATHORN, V. Targeting CD138-/CD20+Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity. In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ISSN 1083-8791, MAY 2016, vol. 22, no. 5, p. 869-878. ISSA, M.E. - BERNDT, S. - CARPENTIER, G. - PEZZUTO, J.M. - CUENDET, M. Bruceantin inhibits multiple myeloma cancer stem cell proliferation. In CANCER BIOLOGY & THERAPY. ISSN 1538-4047, 2016, vol. 17, no. 9, p. 966-975. COUDRE, C. - ALANI, J. - RITCHIE, W. - MARSAUD, V. - SOLA, B. - CAHU, J. HIF-1 and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress. In CELL CYCLE. ISSN 1538-4101, 2016, vol. 15, no. 16, p. 2174-2182. ISSA, Mark E. - CRETTON, Sylvian - CUENDET, Muriel. Targeting Multiple Myeloma Cancer Stem Cells with Natural Products Lessons from Other Hematological Malignancies. In PLANTA MEDICA. ISSN 0032-0943, 2017, vol. 83, no. 9, pp. 752-760. NATONI, A. - SMITH, T. A. G. - KEANE, N. - MCELLISTRIM, C. - CONNOLLY, C. - JHA, A. - ANDRULIS, M. - ELLERT, E. - RAAB, M. S. - GLAVEY, S. V. - KIRKHAM-MCCARTHY, L. - KUMAR, S. K. - LOCATELLI-HOOPS, S. C. - OLIVA, I. - FOGLER, W. E. - MAGNANI, J. L. - O'DWYER, M. E. E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271. In LEUKEMIA. ISSN 0887-6924, 2017, vol. 31, no. 12, pp. 2642-2651. KIKUCHI, Jiro - KURODA, Yoshiaki - KOYAMA, Daisuke - OSADA, Naoki - IZUMI, Tohru - YASUI, Hiroshi - KAWASE, Takakazu - ICHINOHE, Tatsuo - FURUKAWA, Yusuke. Myeloma Cells Are Activated in Bone Marrow Microenvironment by the CD180/MD-1 Complex, Which Senses Lipopolysaccharide. In CANCER RESEARCH. ISSN 0008-5472, 2018, vol. 78, no. 7, pp. 1766-1778. DING, Wanjun - ZENG, Tao - TAO, Weiping - GE, Wei - DENG, Junjian - LEI, Hongbo - XIAO, Yong - LIAO, Fei. Effect of lenalidomide on the human gastric cancer cell line SGC7901/vincristine Notch signaling. In JOURNAL OF CANCER RESEARCH AND THERAPEUTICS. ISSN 0973-1482, 2018, vol. 14, no., pp. S237-S242. FUJII, Shiro - NAKAMURA, Shingen - ODA, Asuka - MIKI, Hirokazu - TENSHIN, Hirofumi - TERAMACHI, Jumpei - HIASA, Masahiro - BAT-ERDENE, Ariunzaya - MAEDA, Yusaku - OURA, Masahiro - TAKAHASHI, Mamiko - IWASA, Masami - ENDO, Itsuro - YOSHIDA, Sumiko - AIHARA, Ken-ichi - KURAHASHI, Kiyoe - HARADA, Takeshi - KAGAWA, Kumiko - NAKAO, Michiyasu - SANO, Shigeki - ABE, Masahiro. Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activity. In BRITISH JOURNAL OF HAEMATOLOGY. ISSN 0007-1048, 2018, vol. 180, no. 2, pp. 246-258. YACCOBY, Shmuel. Two States of Myeloma Stem Cells. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. ISSN 2152-2650, 2018, vol. 18, no. 1, pp. 38-43. TANG, Bo - XU, Aoshuang - XU, Jian - HUANG, Haifan - CHEN, Lei - SU, Yan - ZHANG, Lannan - LI, Junying - FAN, Fengjuan - DENG, Jun - TANG, Liang - SUN, Chunyan - HU, Yu. MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling. In INTERNATIONAL JOURNAL OF CANCER. ISSN 0020-7136, 2018, vol. 142, no. 1, pp. 109-120. MIKI, Hirokazu - NAKAMURA, Shingen - ODA, Asuka - TENSHIN, Hirofumi - TERAMACHI, Jumpei - HIASA, Masahiro - BAT-ERDENE, Ariunzaya - MAEDA, Yusaku - OURA, Masahiro - TAKAHASHI, Mamiko - IWASA, Masami - HARADA, Takeshi - FUJII, Shiro - KURAHASHI, Kiyoe - YOSHIDA, Sumiko - KAGAWA, Kumiko - ENDO, Itsuro - AIHARA, Kenichi - IKUO, Mariko - ITOH, Kohji - HAYASHI, Koichiro - NAKAMURA, Michihiro - ABE, Masahiro. Effective impairment of myeloma cells and their progenitors by hyperthermia. In Oncotarget, 2018-01-01, 9, 12, pp. 10307-10316. PAPADAS, Athanasios - ASIMAKOPOULOS, Fotis. Mechanisms of resistance in multiple myeloma. In Handbook of Experimental Pharmacology. ISSN 01712004, 2018-01-01, 249, pp. 251-288. TANG, Junling - ZHANG, Li - ZHOU, Tiejun - SUN, Zhiwei - KONG, Liangsheng - JING, Li - XING, Hongyun - WU, Hongyan - LIU, Yongli - ZHOU, Shixia - LI, Jingyuan - CHEN, Mei - XU, Fang - TANG, Jirui - MA, Tao - HU, Min - LIU, Dan - GUO, Jing - ZHU, Xiaofeng - CHEN, Yan - YE, Ting - WANG, Jianyu - LI, Xiaoming - XING, H. Rosie. Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma. In GENES & DISEASES. ISSN 2352-4820, 2019, vol. 6, no. 4, pp. 407-418. YAMANOI, Koji - BABA, Tsukasa - ABIKO, Kaoru - HAMANISHI, Junzo - YAMAGUCHI, Ken - MURAKAMI, Ryusuke - TAKI, Mana - HOSOE, Yuko - MURPHY, Susan K. - KONISHI, Ikuo - MANDAI, Masaki - MATSUMURA, Noriomi. Acquisition of a side population fraction augments malignant phenotype in ovarian cancer. In SCIENTIFIC REPORTS. ISSN 2045-2322, 2019, vol. 9, no., pp. ZHANG, Yehua - XU, Chongqing. G allele of rs7853346 polymorphism in PTENP1 enhances the proliferation of multiple myeloma cancer stem cells by promoting the expression of PTENP1 and its downstream signaling molecules. In JOURNAL OF CELLULAR BIOCHEMISTRY. ISSN 0730-2312, 2019, vol. 120, no. 12, pp. 19738-19748. DAMMACCO, Franco - LEONE, Patrizia - SILVESTRIS, Franco - RACANELLI, Vito - VACCA, Angelo. Cancer Stem Cells in Multiple Myeloma and the Development of Novel Therapeutic Strategies. In ONCOGENOMICS: FROM BASIC RESEARCH TO PRECISION MEDICINE, 2019, vol., no., pp. 121-137. WANG, Lei - LIN, Na - LI, Yan. The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma. In ONCOLOGY REPORTS. ISSN 1021-335X, 2019, vol. 41, no. 3, pp. 1678-1690. KIM, Kyoung Ha - CHEONG, Hee-Jeong - LEE, Min Young - LEE, Namsu - LEE, Kyu-Taek - PARK, Seong Kyu - WON, Jong-Ho. Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents. In ANTICANCER RESEARCH. ISSN 0250-7005, 2019, vol. 39, no. 1, pp. 127-133. NAKAGAWA, Makoto - FUJITA, Shuhei - KATSUMOTO, Takuo - YAMAGATA, Kazutsune - OGAWARA, Yoko - HATTORI, Ayuna - KAGIYAMA, Yuki - HONMA, Daisuke - ARAKI, Kazushi - INOUE, Tatsuya - KATO, Ayako - INAKI, Koichiro - WADA, Chisa - ONO, Yoshimasa - YAMAMOTO, Masahide - MIURA, Osamu - NAKASHIMA, Yasuharu - KITABAYASHI, Issay. Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma. In CANCER SCIENCE. ISSN 1349-7006, 2019, vol. 110, no. 1, pp. 194-208. PAPADIMITRIOU, K. - KOSTOPOULOS, I.V. - TSOPANIDOU, A. - OROLOGAS-STAVROU, N. - KASTRITIS, E. - TSITSILONIS, O. - DIMOPOULOS, M.A. - TERPOS, E. Ex Vivo Models Simulating the Bone Marrow Environment and Predicting Response to Therapy in Multiple Myeloma. In CANCERS. AUG 2020, vol. 12, no. 8. WANG, H.Q. - GONG, Y.F. - LIANG, L. - XIAO, L. - YI, H. - YE, M. - ROY, M. - XIA, J.L. - ZHOU, W. - YANG, C.Y. - SHEN, X.K. - ZHANG, B.X. - LI, Z.Z. - LIU, J. - ZHOU, H. - XIAO, X.J. Lycorine targets multiple myeloma stem cell-like cells by inhibition of Wnt/beta-catenin pathway. In BRITISH JOURNAL OF HAEMATOLOGY. ISSN 0007-1048, JUN 2020, vol. 189, no. 6, p. 1151-1164. GAO, M.J. - BAI, H. - JETHAVA, Y. - WU, Y.J. - ZHU, Y.Q. - YANG, Y. - XIA, J.L. - CAO, H.J. - FRANQUI-MACHIN, R. - NADIMINTI, K. - THOMAS, G.S. - SALAMA, M.E. - ALTEVOGT, P. - BISHOP, G. - TOMASSON, M. - JANZ, S. - SHI, J.M. - CHEN, L.J. - FRECH, I. - TRICOT, G. - ZHAN, F.H. Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma. In JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. ISSN 0027-8874, MAY 2020, vol. 112, no. 5, p. 507-515. YANG, Q. - LI, K.H. - LI, X. - LIU, J. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis. In INTERNATIONAL JOURNAL OF MEDICAL SCIENCES. ISSN 1449-1907, 2020, vol. 17, no. 14, p. 2063-2076. BAI, H. - CHEN, B. A 5-Gene Sternness Score for Rapid Determination of Risk in Multiple Myeloma. In ONCOTARGETS AND THERAPY. ISSN 1178-6930, 2020, vol. 13, p. 4339-4348. WANG, L.H. - WANG, Y.T. - WANG, J.F. - LI, L.F. - BI, J.B. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes. In JOURNAL OF IMMUNOLOGY RESEARCH. ISSN 2314-8861, OCT 18 2021, vol. 2021. Dostupné na: https://doi.org/10.1155/2021/3236384. YI, H. - LIANG, L. - WANG, H.Q. - LUO, S.Q. - HU, L. - WANG, Y.P. - SHEN, X.K. - XIAO, L. - ZHANG, Y.B. - PENG, H.L. - DAI, C.W. - YUAN, L.L. - LI, R.J. - GONG, F.J. - LI, Z.Z. - YE, M. - LIU, J. - ZHOU, H. - ZHANG, J. - XIAO, X.J. Albendazole inhibits NF-KB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma. In CANCER LETTERS. ISSN 0304-3835, NOV 1 2021, vol. 520, p. 307-320. Dostupné na: https://doi.org/10.1016/j.canlet.2021.08.009. IKEDA, S. - TAGAWA, H. Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma. In CANCER SCIENCE. ISSN 1347-9032, OCT 2021, vol. 112, no. 10, p. 3995-4004. Dostupné na: https://doi.org/10.1111/cas.15087. GISINA, A.M. - KIM, Y.S. - YARYGIN, K.N. - LUPATOV, A.Y. Identification of the Side Population Associated with ATP-Binding Cassette Transporters Activity Using Imaging Flow Cytometry. In BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY. ISSN 1990-7508, JUL 2021, vol. 15, no. 3, p. 248-254. Dostupné na: https://doi.org/10.1134/S1990750821030033. GUO, W.C. - WANG, H.Q. - CHEN, P. - SHEN, X.K. - ZHANG, B.X. - LIU, J. - PENG, H.L. - XIAO, X.J. Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells. In CANCERS. JUL 2021, vol. 13, no. 14. Dostupné na: https://doi.org/10.3390/cancers13143523. LEIVAS, A. - RISUENO, R.M. - GUZMAN, A. - SANCHEZ-VEGA, L. - PEREZ, M. - MEGIAS, D. - FERNANDEZ, L. - ALONSO, R. - PEREZ-MARTINEZ, A. - RAPADO, I. - MARTINEZ-LOPEZ, J. Natural killer cells efficiently target multiple myeloma clonogenic tumor cells. In CANCER IMMUNOLOGY IMMUNOTHERAPY. ISSN 0340-7004, OCT 2021, vol. 70, no. 10, p. 2911-2924. Dostupné na: https://doi.org/10.1007/s00262-021-02901-y. SUZUKI, K. - NISHIWAKI, K. - YANO, S. Treatment Strategies Considering Micro-Environment and Clonal Evolution in Multiple Myeloma. In CANCERS. JAN 2021, vol. 13, no. 2. Dostupné na: https://doi.org/10.3390/cancers13020215. BASTIN, D.J. - QUIZI, J. - KENNEDY, M.A. - KEKRE, N. - AUER, R.C. Current challenges in the manufacture of clinical-grade autologous whole cell vaccines for hematological malignancies. In CYTOTHERAPY. ISSN 1465-3249, OCT 2022, vol. 24, no. 10, p. 979-989. Dostupné na: https://doi.org/10.1016/j.jcyt.2022.03.010. MARK, C. - CALLANDER, N.S. - CHNG, K. - MIYAMOTO, S. - WARRICK, J. Timelapse viability assay to detect division and death of primary multiple myeloma cells in response to drug treatments with single cell resolution. In INTEGRATIVE BIOLOGY. ISSN 1757-9694, JUN 8 2022, vol. 14, no. 3, p. 49-61. Dostupné na: https://doi.org/10.1093/intbio/zyac006. WANG, H.Q. - XIAO, X.J. - LI, Z.Z. - LUO, S.Q. - HU, L. - YI, H. - XIANG, R.H. - ZHU, Y. - WANG, Y.P. - ZHU, L. - XIAO, L. - DAI, C.W. - AZIZ, A. - YUAN, L.L. - CUI, Y.J. - LI, R.J. - GONG, F.J. - LIU, X.F. - LIANG, L. - PENG, H.L. - ZHOU, H. - LIU, J. Polyphyllin VII, a novel moesin inhibitor, suppresses cell growth and overcomes bortezomib resistance in multiple myeloma. In CANCER LETTERS. ISSN 0304-3835, JUL 1 2022, vol. 537. Dostupné na: https://doi.org/10.1016/j.canlet.2022.215647. SERIZAWA, K. - TANAKA, H. - UEDA, T. - FUKUI, A. - KAKUTANI, H. - TANIGUCHI, T. - INOUE, H. - KUMODE, T. - TANIGUCHI, Y. - RAI, S. - HIRASE, C. - MORITA, Y. - ESPINOZA, J.L. - TATSUMI, Y. - ASHIDA, T. - MATSUMURA, I. CD34(+) myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence. In INTERNATIONAL JOURNAL OF HEMATOLOGY. ISSN 0925-5710, MAR 2022, vol. 115, no. 3, p. 336-349. Dostupné na: https://doi.org/10.1007/s12185-021-03261-0. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2011 Registrované v WOS Registrované v SCOPUS Registrované v CCC DOI 10.1182/blood-2010-02-267344 
článok
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2011 2010 10.558 Q1 6.225 Q1
Počet záznamov: 1